|
|
|
Substance Name: Leridistim [USAN:INN]
RN: 193700-51-5
UNII: WYY7RA43DK
Note
- A recombinant fusion protein containing 14-125 interleukin-3(14-alanine, 50-aspartic acid) fused to granulocyte colony stimulating factor(17-serine).
Molecular Formula
- C1550-H2463-N425-O462-S12
Molecular Weight
- 34828.8127
Classification Code
- Treatment of Chemotherapy-Induced Neutropenia and Thrombocytopenia(Multifunctional Agonist that Activates both Interleukin-3 and G-CSF Receptors)
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Leridistim
- Leridistim [USAN:INN]
Synonyms
- 14-125-Interleukin 3 (14-alanine, 50-aspartic acid) (human reduced) fusion protein with peptide (synthetic) fusion protein with granulocyte colony-stimulating factor (17-serine) (human reduced)
- 14-L-Alanine-50-L-aspartic acid-14-125-interleukin 3 (human reduced) fusion protein with peptide (synthetic) linked fusion protein with 17-L-serinegranulocyte colony-stimulating factor (human reduced). Molecular weight is approximately 32,767 daltons
- Leridistim
- SC 70935
- SC-70935
- UNII-WYY7RA43DK
Systematic Name
- 14-125-Interleukin 3 (14-alanine) (human reduced) fusion protein with peptide (synthetic) fusion protein with granulocyte colony-stimulating factor (17-serine) (human reduced)
Registry Numbers
CAS Registry Number
- 193700-51-5
FDA UNII
- WYY7RA43DK
System Generated Number
- 0193700515